| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 48,565 | 45,736 | 49,872 | 47,293 | | Cost of Revenue | 29,403 | 31,696 | 32,563 | 29,690 | | | Gross Profit | 19,162 | 14,040 | 17,309 | 17,603 | | | Operating Expenses | | Research Development | 1,244 | 1,123 | 1,043 | 1,119 | | Selling General and Administrative | 10,892 | 12,423 | 11,055 | 12,023 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,026 | 494 | 5,211 | 4,461 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 64 | 129 | 152 | 298 | | Earnings Before Interest And Taxes | 7,090 | 623 | 5,363 | 4,759 | | Interest Expense | 28 | 24 | 35 | 38 | | Income Before Tax | 7,062 | 599 | 5,328 | 4,721 | | Income Tax Expense | 2,671 | 46 | 1,712 | 1,809 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,391 | 553 | 3,616 | 2,912 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,391 | 553 | 3,616 | 2,912 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,391 | $553 | $3,616 | $2,912 |
|
0.08% Nasdaq 
0.31%
Income Statement
